Better understanding health through microorganism interactions is a key aspect of the One Health approach.
Whether it's through studying the gut microbiome to develop innovative treatments or nutraceutical products, exploring specific diseases in clinical or preclinical studies, or addressing issues such as pathogenicity, virulence, antibiotic resistance, and the fight against multidrug-resistant infectious agents, scientific and regulatory requirements are becoming increasingly stringent.
At GenoScreen, our goal is to turn science into tailored solutions that meet your specific needs, leveraging our expertise in genomics and microbiology.
Genomics: A central component of future therapeutic and industrial innovation
Research teams are increasingly confronted with multifactorial and complex challenges in areas such as infectious diseases, gastrointestinal health, and oncology.
Simultaneously, industrial stakeholders must ensure the safety, efficacy, and traceability of their products, underpinned by robust, auditable data fully aligned with international regulatory frameworks (GCLP, GMP, EFSA, Novel Food).
Explore our specialized solutions
Clinical microbiome studies
Strengthen your interventional or observational clinical trials with high-resolution, traceable microbiome data, generated under GCLP-compliant workflows, to enhance both scientific validity and regulatory acceptance.
Infectious diseases & antimicrobial resistance
Discover our Deeplex® platform to achieve precise identification of microbial pathogens and detection of resistance-associated mutations (e.g., Mycobacterium tuberculosis, MDR/XDR strains, nosocomial surveillance), supporting translational research and public health
Pharmaceutical & medical biotechnology applications
Perform in-depth characterization and quality control of microbial vectors, vaccine components, and DNA/RNA-based therapeutics using validated genomic and metagenomic approaches, compliant with international standards and regulatory expectations.
Nutraceuticals & botanical extracts
Quantitatively assess the modulatory effects of natural formulations (botanicals, bioactive compounds, or symbiotic complexes) on the gut microbiota and host physiology, ensuring product consistency, stability, and mechanistic understanding.
Probiotics, Prebiotics & Postbiotics
Characterize your strains and ingredients, demonstrate their safety and efficacy, and evaluate their influence on the gut microbiome to accelerate market adoption and regulatory compliance.
LBP – Live Biotherapeutic Products
Secure the development of your live therapeutic products through our genomic, bioinformatics, and GCLP/GMP-compliant expertise; from early characterization to clinical validation.
Start your project now with GenoScreen
The GenoScreen experience in a nutshell...
From setting up your project to delivering the results
Methods and solutions tailored to your projects
Micro-organism studies for over 20 years
Support beyond results delivery
‘materials and methods’ explained
